The Washington Medical Commission said Guito Wingfield, MD, who is based in Centralia, prescribed the drug without documenting sufficient rationale, without informing the patient that the medication was off-label and without performing an appropriate risk analysis.
The order restricts Dr. Wingfield from prescribing ivermectin for non-FDA-approved indications and from prescribing medication or providing care without first establishing a physician-patient relationship, the report said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.